Personalized Prediction of Platelet Transfusion Outcomes in Preterm Infants with Severe Thrombocytopenia

MedXY Editorial Team•Oct 14, 2025•Hematology-Oncology

Prophylactic platelet transfusion in preterm infants with severe thrombocytopenia shows significant individual variability in preventing major bleeding or mortality.
A novel dynamic prediction model was developed and externally validated to estimate 3-day risk of adverse outcomes under two transfusion strategies: prophylaxis versus no prophylaxis.
The model incorporates time-varying clinical factors and transfusion timing to guide individualized transfusion decisions dynamically during the first week after thrombocytopenia onset.
Model validation demonstrated good discrimination and calibration, supporting its potential utility in clinical decision-making for this vulnerable population.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Prophylactic platelet transfusion in preterm infants with severe thrombocytopenia shows significant individual variability in preventing major bleeding or mortality.
A novel dynamic prediction model was developed and externally validated to estimate 3-day risk of adverse outcomes under two transfusion strategies: prophylaxis versus no prophylaxis.
The model incorporates time-varying clinical factors and transfusion timing to guide individualized transfusion decisions dynamically during the first week after thrombocytopenia onset.
Model validation demonstrated good discrimination and calibration, supporting its potential utility in clinical decision-making for this vulnerable population.